{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:58:55Z","timestamp":1793836735359,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ygyno.2021.05.035","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T03:34:03Z","timestamp":1622691243000},"page":"308-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort"],"prefix":"10.1016","volume":"162","author":[{"given":"Jacqueline M.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake R.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amareen","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.05.035_bb0005","doi-asserted-by":"crossref","first-page":"2819372","DOI":"10.1155\/2017\/2819372","article-title":"Socioeconomic and racial\/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities","volume":"2017","author":"Singh","year":"2017","journal-title":"J. Environ. Public Health"},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.035_bb0010","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer."},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.035_bb0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.035_bb0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Preventive Services Task Force","year":"2018","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.035_bb0025","first-page":"321","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American cancer society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0030","author":"American College of Obstetricians and Gynecologists"},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.035_bb0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and Cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0040","author":"Panel on Opportunistic Infections in Adults and Adolescents with HIV"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.035_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2017.03.022","article-title":"An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of Gynecologic Oncology (SGO) recommendations","volume":"146","author":"Salani","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.035_bb0050","first-page":"e111","article-title":"Practice bulletin no. 168: cervical cancer screening and prevention","volume":"128","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.035_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2012.04.037","article-title":"Screening history preceding a diagnosis of cervical cancer in women age 65 and older","volume":"126","author":"Dinkelspiel","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.035_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001585","article-title":"Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study","volume":"11","author":"Casta\u00f1\u00f3n","year":"2014","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.035_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-1609","article-title":"Effect of several negative rounds of human papillomavirus and cytology co-testing on safety against cervical cancer: an observational cohort study","volume":"168","author":"Castle","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.035_bb0070","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.035_bb0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/LGT.0000000000000435","article-title":"Cervical cancer incidence among elderly women in Massachusetts compared with younger women","volume":"22","author":"Feldman","year":"2018","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0080","article-title":"How confident can we be in the current guidelines for exiting cervical screening?","volume":"5","author":"Gravitt","year":"2018","journal-title":"Prev. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.035_bb0085","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/1475-6773.12293","article-title":"Using medical claims for policy effectiveness surveillance: reimbursement and utilization of abdomen\/pelvis computed tomography scans","volume":"50","author":"Horn\u00fd","year":"2015","journal-title":"Health Serv. Res."},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.035_bb0090","doi-asserted-by":"crossref","first-page":"102040","DOI":"10.1016\/j.jogoh.2020.102040","article-title":"Is the age of cervical cancer diagnosis changing over time?","volume":"50","author":"Gnade","year":"2020","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2018.02.004","article-title":"Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old","author":"Diver","year":"2018","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2147\/CIA.S255305","article-title":"Characteristics and treatments of patients aged 65 years or over with cervical cancer","volume":"15","author":"Xie","year":"2020","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.035_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172548","article-title":"Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States. Chang JS, ed","volume":"12","author":"Yoo","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.ygyno.2021.05.035_bb0110","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.035_bb0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ygyno.2020.05.030","article-title":"Historical and projected hysterectomy rates in the USA: implications for future observed cervical cancer rates and evaluating prevention interventions","volume":"158","author":"Simms","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.035_bb0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.amepre.2017.02.024","article-title":"Cervical cancer screening and incidence by age: unmet needs near and after the stopping age for screening","volume":"53","author":"White","year":"2017","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0125","doi-asserted-by":"crossref","first-page":"105880","DOI":"10.1016\/j.ypmed.2019.105880","article-title":"Three large scale surveys highlight the complexity of cervical cancer under-screening among women 45\u201365 years of age in the United States","volume":"130","author":"Harper","year":"2020","journal-title":"Prev. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.035_bb0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/LGT.0000000000000582","article-title":"Survival of older women with cervical cancer based on screening history","volume":"25","author":"Clark","year":"2021","journal-title":"J. Low. Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0135","first-page":"149","article-title":"Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study","volume":"19","author":"Castanon","year":"2021","journal-title":"Prev Med."},{"issue":"21","key":"10.1016\/j.ygyno.2021.05.035_bb0140","first-page":"00347","article-title":"It's time to re-evaluate cervical Cancer screening after age 65","volume":"S0090\u20138258","author":"Dilley","year":"2021","journal-title":"Gynecol Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.035_bb0145","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/ijc.32950","article-title":"A study of the risks of CIN3+ detection after multiple rounds of HPV testing: results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California","volume":"147","author":"Hammer","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.035_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.10.011","article-title":"Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus","volume":"222","author":"Stewart","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.035_bb0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amepre.2014.04.018","article-title":"Opting out of cervical cancer screening","volume":"47","author":"Cooper","year":"2014","journal-title":"Am. J. Prev. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.035_bb0160","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ypmed.2013.04.012","article-title":"Primary care provider practices and beliefs related to cervical cancer screening with the HPV test in federally qualified health centers","volume":"57","author":"Roland","year":"2013","journal-title":"Prev. Med."},{"issue":"11","key":"10.1016\/j.ygyno.2021.05.035_bb0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch. Intern. Med."},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.035_bb0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA."},{"issue":"12","key":"10.1016\/j.ygyno.2021.05.035_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208482","article-title":"Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives","volume":"13","author":"McSherry","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ygyno.2021.05.035_bb0180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/amiajnl-2012-000820","article-title":"Clinical decision support with automated text processing for cervical cancer screening","volume":"19","author":"Wagholikar","year":"2012","journal-title":"J. Am. Med. Inform. Assoc. JAMIA."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.035_bb0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0037-1617451","article-title":"Improving the accuracy of a clinical decision support system for cervical cancer screening and surveillance","volume":"9","author":"Ravikumar","year":"2018","journal-title":"Appl. Clin. Inform."},{"key":"10.1016\/j.ygyno.2021.05.035_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/2150132720958832","article-title":"Understanding user acceptance of clinical decision support systems to promote increased cancer screening rates in a primary care practice","volume":"11","author":"Kelsey","year":"2020","journal-title":"J. Prim. Care Community Health"},{"key":"10.1016\/j.ygyno.2021.05.035_bb0195","doi-asserted-by":"crossref","first-page":"106271","DOI":"10.1016\/j.cct.2021.106271","article-title":"Design and rationale of an intervention to improve cancer prevention using clinical decision support and shared decision making: a clinic-randomized trial","volume":"102","author":"Elliott","year":"2021","journal-title":"Contemp. Clin. Trials."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821004418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821004418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:23Z","timestamp":1758772583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821004418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0090825821004418"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.035","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}